Comparison of Mood Disorders Screening Scales in Geriatric Oncology

NCT02799524 | Completed

• 2 other identifiers: 2015-A00836-4315-087
• Study Type: observational
• Target: 93
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of this study is to evaluate the scales commonly used in geriatrics and oncology distress thermometer ( analogue scale rated from 0 to 1 for the emotional distress ) , the GDS15 (15 issues closed binary response seeking signs of depression ) the HADS (14 questions assessing the intensity of anxiety signs and signs of depression listed 0-3 ). The prospective observational study will be conducted in parallel on two sites ( University Hospital Centre and François Baclesse ) after informed patient information. It will be offered to patients 70 years and over with a new diagnosis or relapse of cancer or haematological malignancies in the hospital to meet the mood disorder screening questionnaires .

Conditions

Mood Disorders

Outcome Measures

Primary Outcomes (1)

• Concordance degrees Assessment (HADS and GDS )

  Concordance degrees Assessment of each of 2 scales ( HADS and GDS ) from the DSM- V , for diagnostic confirmation of major depressive episodes in elderly patients with cancer or haematological malignancies

  3 weeks

Secondary Outcomes (3)

• Correlation between the presence of signs of depression screening by HADS -D ( ≥11 / 21) and GDS ( > 5/15)

  3 weeks

• correlation between anxious signs of HADS -A ( ≥11 / 21) and the distress thermometer ( ≥4 / 10) and factors outcome 2

  3 weeks

• Comparison of the distress thermometer score between screening and revaluation to 3 weeks

  3 weeks

Interventions

comparison of screening scales OTHER

Concordance degrees Assessment of each of 2 scales ( HADS and GDS ) from the DSM- V , for diagnostic confirmation of major depressive episodes in elderly patients with cancer or haematological malignancies

Eligibility Criteria

• Age: 70 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Men and women 70 years and older with newly diagnosed or relapsed cancer or haematological malignancies (not older than one month)

You may qualify if:

• Patient 70 years and older with diagnosis of cancer or haematological malignancies ,
• New diagnosis or relapse announced
• Supported in the 2 c among : in consultation , or hospital geriatric or oncology / hematology specialty
• Affiliated Health Insurance

You may not qualify if:

• Cognitive problems preventing self

Sponsors & Collaborators

• University Hospital, Caen: lead
• Centre Francois Baclesse: collaborator

Study Sites (1)

Caen UH

Caen, 14033, France

Location

MeSH Terms

Conditions

Mood Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 1, 2016
• First Posted: June 15, 2016
• Study Start: December 1, 2015
• Primary Completion: December 1, 2016
• Study Completion: July 1, 2017
• Last Updated: August 21, 2017

Record last verified: 2017-01

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)